As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

This article explores how digital maturity in process design and parameter management can drive significant time and cost savings, streamline tech transfers and ultimately accelerate patient access to ...

Integrating genomics and AI is key to increasing the probability of success and accelerating the delivery of treatments to ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Five months after the matter was seemingly closed, a lawsuit fighting to make Prince Harry’s private US visa records public will reopen in court on Wednesday. At such a critical moment in US history, ...

With its GDP achieving a five percent growth year on year in 2024, China made great strides in its high-quality development, with trade and investment playing a crucial role in it. China is now a ...

In addition to supporting NurExone's internal drug development efforts, Exo-Top will be positioned to supply high-quality exosomes to other pharmaceutical ... greater control over its exosome ...

The Federal Medical Centre (FMC) Jalingo has reaffirmed its commitment to providing quality healthcare and making drugs available in the hospital for people accessing the facility. A senior staff ...